Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trigeminal sensory afferent fibers are the primary neurons responsible for conveying sensory information, including pain, temperature, and touch, from the face, scalp, and intracranial structures like the meninges to the central nervous system (StatPearls, 2023). These fibers have their cell bodies located in the trigeminal ganglion and consist of distinct subpopulations, primarily A-delta and C-fibers, which are critical for the transmission of nociceptive signals (The Journal of Headache and Pain, 2018). In pathological conditions such as migraine and trigeminal neuralgia, these fibers exhibit hyperexcitability and release pro-inflammatory neuropeptides, including calcitonin gene-related peptide (CGRP) and substance P, which contribute to neurogenic inflammation and pain (NINDS, 2023). Therapeutic strategies often target specific molecular components of these fibers, such as voltage-gated sodium channels to stop signal firing or CGRP receptors to interrupt the pain signaling cascade (Nature Reviews Disease Primers, 2016). Although this entry describes an anatomical and cellular system rather than a single molecule, these fibers represent the fundamental pathway targeted by many craniofacial analgesics and anti-migraine medications.
Drugs modulate these fibers by inhibiting voltage-gated sodium channels (such as Nav1.7 and Nav1.8) to arrest action potential propagation, activating presynaptic inhibitory serotonin 5-HT1B/1D receptors to block the release of vasoactive neuropeptides, or antagonizing Calcitonin Gene-Related Peptide (CGRP) and its receptor to mitigate neurogenic inflammation and peripheral sensitization (StatPearls, 2023; Nature Reviews Disease Primers, 2016).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trigeminal sensory afferent fiber.